PTGXProtagonist Therapeutics Inc

CUSIP: 74366E102

Guru Owners

$15.7M

Total Value Held

180,049

Total Shares

Investor	Fund	Shares	Value▼	% of Portfolio	Rpt Price	Period
Stanley Druckenmiller	Duquesne Family Office	159700	$13.9M	0.31%	$87.34	Q4 2025
Polen Capital	Polen Capital Management	20349	$1.8M	0.01%	$87.34	Q4 2025

Stanley Druckenmiller

$13.9M

0.31%

Polen Capital

$1.8M

0.01%

📊 Fundamentals

Market Cap$6.2B

Forward P/E-165.3x

P/FCF58.4x

EPS (TTM)$-2.05

Revenue (TTM)$46.0M

Profit Margin-282.83%

Beta2.24

52-Week Range

$39.60

$97.53

Current: $96.66

Data from Yahoo Finance · refreshed every 4 hours

📊 Holdings Over Time

How superinvestor ownership has changed across quarters

Quarter-by-Quarter Activity

Q4 '252 owners · $15.7M

INCREASEDPolen Capital$1.8M

Q3 '252 owners · $12.0M

NEWStanley Druckenmiller$10.6M

INCREASEDPolen Capital$1.4M

Q2 '251 owners · $884K

No changes

💰 DCF Calculator

DCF model · 10-yr forecast

Estimates depend entirely on your assumptions. Adjust the inputs below to explore scenarios.

📊 Adjust the assumptions below to calculate an estimated fair value

Projection Period

Revenue Growth Rate

0%analyst est. -65.5%

0%100%

Growth Decay Rate

15%

0% (no decay)50% (fast decay)

Terminal Growth Rate

3.0%

0%5%

FCF Margin

50.0%current: 229.5%

1%50%

Discount Rate (WACC)

8.0%typical: 8% large caps · 10% growth

5%20%

Model: 10-year DCF · 3.0% terminal growth · Based on Yahoo Finance data